Submitted by Anonymous (not verified) on 2 September 2025 - 8:40
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised
Source: